Loading clinical trials...
Loading clinical trials...
A Phase II, Open-Label, Multicenter Trial to Investigate the Clinical Activity and Safety of Avelumab (MSB0010718C) in Subjects With Merkel Cell Carcinoma
Conditions
Interventions
Avelumab
Locations
61
United States
UCLA Medical Center
Los Angeles, California, United States
The Angeles Clinic and Research Institute - West LA
Los Angeles, California, United States
University of Colorado
Aurora, Colorado, United States
H. Lee Moffitt Cancer Center and Research Institute, Inc
Tampa, Florida, United States
National Cancer Institute
Bethesda, Maryland, United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Start Date
July 3, 2014
Primary Completion Date
May 2, 2019
Completion Date
May 3, 2023
Last Updated
March 13, 2024
Lead Sponsor
EMD Serono Research & Development Institute, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions